Your browser doesn't support javascript.
loading
Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.
Kuo, Christopher; Foon, Dione; Waters, Kaaren; Cheung, Clement; Margol, Ashley S.
Affiliation
  • Kuo C; Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California.
  • Foon D; Cancer and Blood Disease Institute and Division of Hematology Oncology, Children's Hospital Los Angeles, Los Angeles, California.
  • Waters K; Cancer and Blood Disease Institute and Division of Hematology Oncology, Children's Hospital Los Angeles, Los Angeles, California.
  • Cheung C; Division of Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California.
  • Margol AS; Keck School of Medicine, University of Southern California, Los Angeles, California.
Pediatr Blood Cancer ; 67(12): e28516, 2020 12.
Article in En | MEDLINE | ID: mdl-32573959

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Neoplasms, Neuroepithelial / Antineoplastic Agents, Alkylating / Diabetes Insipidus, Neurogenic / Rare Diseases / Temozolomide Type of study: Prognostic_studies Limits: Child / Humans / Male Language: En Journal: Pediatr Blood Cancer Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Neoplasms, Neuroepithelial / Antineoplastic Agents, Alkylating / Diabetes Insipidus, Neurogenic / Rare Diseases / Temozolomide Type of study: Prognostic_studies Limits: Child / Humans / Male Language: En Journal: Pediatr Blood Cancer Year: 2020 Document type: Article